VitaSpring Biomedical

(OTC) VSBC

Current Price$0.01

Market Cap$2.30M

Since IPO (2019)-97%

5 Year-100%

1 Year-93%

1 Month-99%

VitaSpring Biomedical Financials at a Glance

Market Cap

$2.30M

Revenue (TTM)

$0.00

Net Income (TTM)

-$410.67K

EPS (TTM)

-$0.00

P/E Ratio

-3.58

Dividend

$0.00

Beta (Volatility)

4.69 (High)

Dividend

$0.00

Beta (Volatility)

4.69 (High)

Price

$0.01

Volume

408

Open

$0.01

Price

$0.01

Volume

408

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $1.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

4.69 (High)

Price

$0.01

Volume

408

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $1.00

Estimated Earnings Date

N/A

VSBC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VitaSpring Biomedical

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ssu-Chuan Lai, PhD

Website

www.vitaspringbio.com

Headquarters

Irvine, CA 92618, US

VSBC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-36%

Earnings Yield

-27.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.30M

Shares Outstanding

207.03M

Volume

408

Avg. Volume

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$385.41K

EBITDA

-$385.41K

Operating Cash Flow

-$2.69K

Capital Expenditure

$0.00

Free Cash Flow

-$2.69K

Cash & ST Invst.

$2.08K

Total Debt

$0.00

VitaSpring Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2027YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$2.30M

N/A

Market Cap/Employee

$2.30M

N/A

Employees

N/A

Net Income

-$75.84K

+45.0%

EBITDA

-$75.84K

+57.7%

Quarterly Fundamentals

Name

Q1 2027YOY CHG

Total Cash

$8.17K

-66.0%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-35.92%

N/A

Return on Invested Capital

8.70%

N/A

Free Cash Flow

$6.08K

+147.3%

Operating Cash Flow

$6.08K

+147.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IUGNFImugene Limited

IUGNFImugene Limited$0.10-5.00%

AURXNuo Therapeutics, Inc.

AURXNuo Therapeutics, Inc.$0.99+9.43%

SPHRYStarpharma Holdings Limited

SPHRYStarpharma Holdings Limited$5.00+8.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.94+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$83.05+0.07%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.33+0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.73-0.07%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$35.51-0.02%

INTCIntel

INTCIntel$134.10+0.11%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$179.75-0.06%

Questions About VSBC

What is the current price of VitaSpring Biomedical?

VitaSpring Biomedical is trading at $0.01 per share.

What is the 52-week range for VitaSpring Biomedical?

Over the past 52 weeks, VitaSpring Biomedical has traded between $0.01 and $1.00.

How much debt does VitaSpring Biomedical have?

As of the most recent reporting period, VitaSpring Biomedical reported total debt of $0.00.

How much cash does VitaSpring Biomedical have on hand?

VitaSpring Biomedical reported $8.17K in cash and cash equivalents in its most recent financial results.

What is VitaSpring Biomedical’s dividend yield?

VitaSpring Biomedical does not currently have a dividend yield.

VitaSpring Biomedical

VitaSpring Biomedical Financials at a Glance

VSBC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About VitaSpring Biomedical

VSBC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

VitaSpring Biomedical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VSBC

What is the current price of VitaSpring Biomedical?

What is the 52-week range for VitaSpring Biomedical?

How much debt does VitaSpring Biomedical have?

How much cash does VitaSpring Biomedical have on hand?

What is VitaSpring Biomedical’s dividend yield?

Premium Investing Services